- Home
- WEAV vs CSTL Comparison
WEAV vs CSTL Comparison
Compare WEAV & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEAV
- CSTL
- Stock Information
- Founded
- WEAV 2011
- CSTL 2007
- Country
- WEAV United States
- CSTL United States
- Employees
- WEAV N/A
- CSTL N/A
- Industry
- WEAV EDP Services
- CSTL Medical Specialities
- Sector
- WEAV Technology
- CSTL Health Care
- Exchange
- WEAV Nasdaq
- CSTL Nasdaq
- Market Cap
- WEAV 940.8M
- CSTL 832.4M
- IPO Year
- WEAV 2021
- CSTL 2019
- Fundamental
- Price
- WEAV $13.43
- CSTL $33.06
- Analyst Decision
- WEAV Strong Buy
- CSTL Strong Buy
- Analyst Count
- WEAV 3
- CSTL 5
- Target Price
- WEAV $16.33
- CSTL $33.40
- AVG Volume (30 Days)
- WEAV 641.6K
- CSTL 381.4K
- Earning Date
- WEAV 10-30-2024
- CSTL 11-04-2024
- Dividend Yield
- WEAV N/A
- CSTL N/A
- EPS Growth
- WEAV N/A
- CSTL N/A
- EPS
- WEAV N/A
- CSTL N/A
- Revenue
- WEAV $186,995,000.00
- CSTL $287,589,000.00
- Revenue This Year
- WEAV $20.84
- CSTL $37.67
- Revenue Next Year
- WEAV $15.61
- CSTL N/A
- P/E Ratio
- WEAV N/A
- CSTL N/A
- Revenue Growth
- WEAV 20.53
- CSTL 71.67
- 52 Week Low
- WEAV $6.67
- CSTL $12.23
- 52 Week High
- WEAV $13.80
- CSTL $34.50
- Technical
- Relative Strength Index (RSI)
- WEAV 69.64
- CSTL 62.72
- Support Level
- WEAV $12.94
- CSTL $27.65
- Resistance Level
- WEAV $13.75
- CSTL $34.50
- Average True Range (ATR)
- WEAV 0.37
- CSTL 1.35
- MACD
- WEAV 0.01
- CSTL 0.45
- Stochastic Oscillator
- WEAV 80.12
- CSTL 79.25
About WEAV Weave Communications Inc.
Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, it enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue primarily from subscription services.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.